Craig C. Hopkinson - Feb 18, 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 18, 2022
Transactions value $
-$271,651
Form type
4
Date filed
2/23/2022, 03:40 PM
Previous filing
Feb 17, 2022
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Sale -$58K -2.31K -19.54% $25.17 9.5K Feb 18, 2022 Direct F1
transaction ALKS Ordinary Shares Options Exercise +10.1K +106.32% 19.6K Feb 20, 2022 Direct F2
transaction ALKS Ordinary Shares Tax liability -$74.4K -2.97K -15.14% $25.08 16.6K Feb 20, 2022 Direct
transaction ALKS Ordinary Shares Options Exercise +6.88K +41.35% 23.5K Feb 21, 2022 Direct F2
transaction ALKS Ordinary Shares Tax liability -$50.7K -2.02K -8.6% $25.08 21.5K Feb 21, 2022 Direct
transaction ALKS Ordinary Shares Options Exercise +12K +56.04% 33.5K Feb 22, 2022 Direct F2
transaction ALKS Ordinary Shares Tax liability -$88.5K -3.54K -10.56% $25.01 30K Feb 22, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Employee Stock Option (Right to Buy) Award $0 +140K $0.00 140K Feb 18, 2022 Ordinary Shares 140K $25.08 Direct F3
transaction ALKS Restricted Stock Unit Award Award $0 +34.9K $0.00 34.9K Feb 18, 2022 Ordinary Shares 34.9K $0.00 Direct F4
transaction ALKS Restricted Stock Unit Award Options Exercise -10.1K -33.33% 20.2K Feb 20, 2022 Ordinary Shares 10.1K $0.00 Direct F2, F5
transaction ALKS Restricted Stock Unit Award Options Exercise -6.88K -50% 6.88K Feb 21, 2022 Ordinary Shares 6.88K $0.00 Direct F2, F6
transaction ALKS Restricted Stock Unit Award Options Exercise -12K -25% 36.1K Feb 22, 2022 Ordinary Shares 12K $0.00 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Restricted stock units convert into ordinary shares on a one-for-one basis.
F3 Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.
F4 Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/18/2023.
F5 Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021.
F6 Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.
F7 Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022.